PAR 3.77% 25.5¢ paradigm biopharmaceuticals limited..

New orphan drug designation, page-5

  1. 812 Posts.
    lightbulb Created with Sketch. 203
    It has been designated as an orphan drug. The initial stage of the process. I think approval is the last stage before we can sell. It's great news There are some nice short and long term benefits.

    PharmD
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
25.5¢
Change
-0.010(3.77%)
Mkt cap ! $89.19M
Open High Low Value Volume
27.0¢ 27.0¢ 25.5¢ $162.7K 620.9K

Buyers (Bids)

No. Vol. Price($)
2 25008 25.5¢
 

Sellers (Offers)

Price($) Vol. No.
26.0¢ 34768 1
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.